Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 618

1.

Perturbed endoplasmic reticulum function, synaptic apoptosis and the pathogenesis of Alzheimer's disease.

Mattson MP, Gary DS, Chan SL, Duan W.

Biochem Soc Symp. 2001;(67):151-62. Review.

PMID:
11447832
2.

Neuronal and glial calcium signaling in Alzheimer's disease.

Mattson MP, Chan SL.

Cell Calcium. 2003 Oct-Nov;34(4-5):385-97. Review.

PMID:
12909083
3.
4.

Presenilin 1 regulates the processing of beta-amyloid precursor protein C-terminal fragments and the generation of amyloid beta-protein in endoplasmic reticulum and Golgi.

Xia W, Zhang J, Ostaszewski BL, Kimberly WT, Seubert P, Koo EH, Shen J, Selkoe DJ.

Biochemistry. 1998 Nov 24;37(47):16465-71.

PMID:
9843412
6.

Neurons overexpressing mutant presenilin-1 are more sensitive to apoptosis induced by endoplasmic reticulum-Golgi stress.

Terro F, Czech C, Esclaire F, Elyaman W, Yardin C, Baclet MC, Touchet N, Tremp G, Pradier L, Hugon J.

J Neurosci Res. 2002 Aug 15;69(4):530-9.

PMID:
12210846
7.

Presenilins, the endoplasmic reticulum, and neuronal apoptosis in Alzheimer's disease.

Mattson MP, Guo Q, Furukawa K, Pedersen WA.

J Neurochem. 1998 Jan;70(1):1-14. Review.

8.
9.

Cellular and molecular mechanisms underlying perturbed energy metabolism and neuronal degeneration in Alzheimer's and Parkinson's diseases.

Mattson MP, Pedersen WA, Duan W, Culmsee C, Camandola S.

Ann N Y Acad Sci. 1999;893:154-75. Review.

PMID:
10672236
10.

Presenilin mutations and calcium signaling defects in the nervous and immune systems.

Mattson MP, Chan SL, Camandola S.

Bioessays. 2001 Aug;23(8):733-44. Review.

PMID:
11494322
12.

Altered calcium signaling and neuronal injury: stroke and Alzheimer's disease as examples.

Mattson MP, Rydel RE, Lieberburg I, Smith-Swintosky VL.

Ann N Y Acad Sci. 1993 May 28;679:1-21. Review.

PMID:
8512177
13.

Presenilins and Alzheimer's disease: biological functions and pathogenic mechanisms.

Czech C, Tremp G, Pradier L.

Prog Neurobiol. 2000 Mar;60(4):363-84. Review.

PMID:
10670705
15.
16.
18.

Presenilin-1 P264L knock-in mutation: differential effects on abeta production, amyloid deposition, and neuronal vulnerability.

Siman R, Reaume AG, Savage MJ, Trusko S, Lin YG, Scott RW, Flood DG.

J Neurosci. 2000 Dec 1;20(23):8717-26.

19.

Amyloid precursor protein, presenilins, and alpha-synuclein: molecular pathogenesis and pharmacological applications in Alzheimer's disease.

Suh YH, Checler F.

Pharmacol Rev. 2002 Sep;54(3):469-525. Review. Erratum in: Pharmacol Rev. 2006 Jun;58(2):280.

20.

Involvement of Gadd153 in the pathogenic action of presenilin-1 mutations.

Milhavet O, Martindale JL, Camandola S, Chan SL, Gary DS, Cheng A, Holbrook NJ, Mattson MP.

J Neurochem. 2002 Nov;83(3):673-81.

Supplemental Content

Support Center